Palonosetron (Aloxi): A Second-Generation 5-Ht3 Receptor Antagonist for Chemotherapy-Induced Nausea and Vomiting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Palonosetron (Aloxi): A Second-Generation 5-Ht3 Receptor Antagonist for Chemotherapy-Induced Nausea and Vomiting

Published:2006-10 Issue:4 Volume:19 Page:413-416
ISSN:0899-8280
Container-title:Baylor University Medical Center Proceedings
language:en
Short-container-title:Baylor University Medical Center Proceedings

Author:

Leon Andrew De

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/08998280.2006.11928210

Reference14 articles.

1. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics

2. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro

3. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

4. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytoconstituents Targeting the Serotonin 5-HT₃ Receptor: Promising Therapeutic Strategies for Neurological Disorders;ACS Pharmacology & Translational Science;2024-06-04

2. Differentiating enantiomers by directional rotation of ions in a mass spectrometer;Science;2024-02-09

3. A suspected case of serotonin syndrome induced by palonosetron and ramosetron administration;Journal of Exercise Rehabilitation;2023-10-25

4. Stability indicating potentiometric method for the determination of palonosetron HCl using two different sensors;Scientific Reports;2022-07-28

5. Comparative Study Between Fosaprepitant and Palonosetron in the Prophylaxis of Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy: Prospective, Randomized and Double-Blind Study;Frontiers in Pharmacology;2022-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3